Â鶹ѧÉú¾«Æ·°æ

Skip to main content
Bogdana Schmidt
( out of 359 reviews )

Bogdana Schmidt, MD, MPH

Languages spoken: English, Russian, Spanish, Ukrainian

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital South

Clinic 2B, Urology
Salt Lake City
801-587-4381

Veterans Administration Medical Center

Salt Lake City
  • Bogdana Schmidt, MD, MPH, is a urologic surgeon at the University of Utah in Salt Lake City, Utah. Dr. Schmidt specializes in urologic oncology. She attended University of San Francisco, School of Medicine and stayed to complete her residency training there. She then completed a Society of Urologic Oncology fellowship at Stanford University.

    Dr. Schmidt’s clinical interests include:

    • The treatment of bladder cancer, kidney cancer, prostate cancer, testis cancer, and penile cancer.

    • Novel imaging technologies

    • Organ preservation

    • Minimally invasive/robotic urology procedures.

    Dr. Schmidt’s research interests focus on:

    • Improving patient risk stratification and optimization of surgical outcomes

    • Quality improvement in urologic oncology

    • Addressing health disparities in urologic oncology

    • The integration of artificial intelligence and advanced imaging techniques into urologic care

    Patient Rating

    4.9 /5
    ( out of 359 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    January 25, 2025
    HUNTSMAN CANCER CENTER

    Trust her with my life!

    January 23, 2025
    HUNTSMAN CANCER CENTER

    She is a fabulous doctor! She never feels rushed and totally listens and answers your questions. She is very knowledgeable and takes the time to teach you about your condition. She is very honest and straightforward with you. She is willing to take whatever time is needed to help you understand all the ramifications of your disease. She is very respectful of your feelings and concerns. I feel extremely confident in her ability to treat my disease. I would highly recommend and encourage anyone to have her be their physician.

    January 23, 2025
    HUNTSMAN CANCER CENTER

    Dr. Schmidt has always had such a great attitude and she communicates complicated issues clearly and in a way that the patient can understand. She's a rock star!

    January 16, 2025
    HUNTSMAN CANCER CENTER

    Dr. Schmidt is a very caring and competent physician. After meeting with her and talking with her about my medical concerns, I am completely confident in her and trust that she will use excellent judgement for my care.

    January 15, 2025
    HUNTSMAN CANCER CENTER

    Dr. Bogdana Schmidt is one of the best doctors I have ever had. She is very courteous and a great doctor.

    December 20, 2024
    HUNTSMAN CANCER CENTER

    Dr Schmidt is extremely knowledgeable about the most current and effective treatment options for prostate cancer. She listens carefully and provides informative feedback. I never felt rushed, and I was always treated with respect and compassion.

    December 20, 2024
    HUNTSMAN CANCER CENTER

    Dr. Schmidt is a very accomplished surgeon and has treated me very well over the years.

    December 19, 2024
    HUNTSMAN CANCER CENTER

    Good communication and pleasant

    December 18, 2024
    HUNTSMAN CANCER CENTER

    An amazing surgeon and physician who treats patients with courtesy and respect. She is personable and caring and leaves me feeling like I'm her only patient.

  • Bogdana Schmidt, MD, MPH, is a urologic surgeon at the University of Utah in Salt Lake City, Utah. Dr. Schmidt specializes in urologic oncology. She attended University of San Francisco, School of Medicine and stayed to complete her residency training there. She then completed a Society of Urologic Oncology fellowship at Stanford University.

    Dr. Schmidt’s clinical interests include:

    • The treatment of bladder cancer, kidney cancer, prostate cancer, testis cancer, and penile cancer.

    • Novel imaging technologies

    • Organ preservation

    • Minimally invasive/robotic urology procedures.

    Dr. Schmidt’s research interests focus on:

    • Improving patient risk stratification and optimization of surgical outcomes

    • Quality improvement in urologic oncology

    • Addressing health disparities in urologic oncology

    • The integration of artificial intelligence and advanced imaging techniques into urologic care

    Board Certification and Academic Information

    Academic Departments Surgery -Primary
    Academic Divisions Urology

    Education history

    Fellowship Urologic Oncology - Stanford University Fellow
    Residency Urologic Surgery - University of California, San Francisco Resident
    Internship General Surgery - University of California, San Francisco Intern
    Professional Medical Medicine - University of California, San Francisco School of Medicine M.D.
    Graduate Training Community Health Science - University of California, Los Angeles M.P.H.
    Undergraduate Physiological Science - University of California, Los Angeles B.S.

    Selected Publications

    Journal Article

    1. Sung D, Schmidt B, Tward JD (2024). The Ability of the STAR-CAP Staging System to Prognosticate the Risk of Subsequent Therapies and Metastases After Initial Treatment of M0 Prostate Cancer. Clin Genitourin Cancer. ()
    2. Hutten R, Khouri A, Parsons M, Tward A, Wilson T, Peterson J, Morrell G, Dechet C, ONeil B, Schmidt B, Kokeny K, Lloyd S, Cannon D, Tward J, Sanchez A, Johnson S (2022). The Clinical Significance of Maximum Tumor Diameter on MRI in Men Undergoing Radical Prostatectomy or Definitive Radiotherapy for Locoregional Prostate Cancer. Clin Genitourin Cancer, 20(6), e453-e459. ()
    3. Schmidt B, Velaer KN, Thomas IC, Ganesan C, Song S, Pao AC, Thong AE, Liao JC, Chertow GM, Skinner EC, Leppert JT (2022). Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer. Eur Urol Open Sci, 35, 29-36. ()
    4. Vilson FL, Schmidt B, White L, Sorensen SJC, Ganesan C, Pao AC, Enemchukwu E, Chertow GM, Leppert JT (2021). Removing Race from eGFR calculations: Implications for Urologic Care. Urology. ()
    5. Schmidt B, Leppert JT (2021). Costs of Robotic-Assisted Radical Prostatectomy 1 Year After Surgery: Pay Now and Save Later? JAMA Netw Open, 4(3), e212548. ()
    6. Schmidt B, Bhambhvani HP, Greenberg DR, Prado K, Shafer S, Thong A, Gill H, Skinner E, Shah JB (2020). Bupivacaine local anesthetic to decrease opioid requirements after radical cystectomy: Does formulation matter? Urol Oncol. ()
    7. Schmidt B, Eapen RS, Cowan JE, Broering JM, Greene KL, Carroll PR, Cooperberg MR (2018). Practice patterns of primary EBRT with and without ADT in prostate cancer treatment. Prostate Cancer Prostatic Dis, 22(1), 117-124. ()
    8. Schmidt B, Meng MV, Hampson LA (2018). Operating Room Supply Cost Awareness: A Cross-Sectional Analysis. Urol Pract, 6(2), 73-78. ()
    9. Truesdale MD, Elmer-Dewitt M, Sandri M, Schmidt B, Metzler I, Gadzinski A, Stoller ML, Chi T (2016). Methylene Blue Injection as an Alternative to Antegrade Nephrostography to Assess Urinary Obstruction After Percutaneous Nephrolithotomy. J Endourol, 30(4), 476-82. ()
    10. Schmidt B, Copp HL (2015). Work-up of Pediatric Urinary Tract Infection. Urol Clin North Am, 42(4), 519-26. ()
    11. Kovshilovskaya B, Chi T, Miller J, Stoller ML (2016). Systemic implications of urinary stone disease. Transl Androl Urol, 1(2), 89-96. ()
    12. Weiss DA, Kovshilovskaya B, Breyer BN (2011). Gender trends of urology manuscript authors in the United States: a 35-year progression. J Urol, 187(1), 253-8. ()
    13. Call GB, Olson JM, Chen J, Villarasa N, Ngo KT, Yabroff AM, Cokus S, Pellegrini M, Bibikova E, Bui C, Cespedes A, Chan C, Chan S, Cheema AK, Chhabra A, Chitsazzadeh V, Do MT, Fang QA, Folick A, Goodstein GL, Huang CR, Hung T, Kim E, Kim W, Kim Y, Kohan E, Kuoy E, Kwak R, Lee E, Lee J, Lin H, Liu HC, Moroz T, Prasad T, Prashad SL, Patananan AN, Rangel A, Rosselli D, Sidhu S, Sitz D, Taber CE, Tan J, Topp K, Tran P, Tran QM, Unkovic M, Wells M, Wickland J, Yackle K, Yavari A, Zaretsky JM, Allen CM, Alli L, An J, Anwar A, Arevalo S, Ayoub D, Badal SS, Baghdanian A, Baghdanian AH, Baumann SA, Becerra VN, Chan HJ, Chang AE, Cheng XA, Chin M, Chong F, Crisostomo C, Datta S, Delosreyes A, Diep F, Ekanayake P, Engeln M, Evers E, Farshidi F, Fischer K, Formanes AJ, Gong J, Gupta R, Haas BE, Hahm V, Hsieh M, Hui JZ, Iao ML, Jin SD, Kim AY, Kim LS, King M, Knudsen-Robbins C, Kohanchi D, Kovshilovskaya B, Ku A, Kung RW, Landig ME, Latterman SS, Lauw SS, Lee DS, Lee JS, Lei KC, Leung LL, Lerner R, Lin JY, Lin K, Lim BC, Lui CP, Liu TQ, Luong V, Makshanoff J, Mei AC, Meza M, Mikhaeil YA, Moarefi M, Nguyen LH, Pai SS, Pandya M, Patel AR, Picard PD, Safaee MM, Salame C, Sanchez C, Sanchez N, Seifert CC, Shah A, Shilgevorkyan OH, Singh I, Soma V, Song JJ, Srivastava N, StaAna JL, Sun C, Tan D, Teruya AS, Tikia R, Tran T, Travis EG, Trinh JD, Vo D, Walsh T, Wong RS, Wu K, Wu YW, Yang NX, Yeranosian M, Yu JS, Zhou JJ, Zhu RX, Abrams A, Abramson A, Amado L, Anderson J, Bashour K, Beyer E, Bookatz A, Brewer S, Buu N, Calvillo S, Cao J, Chan A, Chan J, Chang A, Chang D, Chang Y, Chen Y, Choi J, Chou J, Dang P, Datta S, Davarifar A, Deravanesian A, Desai P, Fabrikant J, Farnad S, Fu K, Garcia E, Garrone N, Gasparyan S, Gayda P, Go S, Goffstein C, Gonzalez C, Guirguis M, Hassid R, Hermogeno B, Hong J, Hong A, Hovestreydt L, Hu C, Huff D, Jamshidian F, Jen J, Kahen K, Kao L, Kelley M, Kho T, Kim Y, Kim S, Kirkpatrick B, Langenbacher A, Laxamana S, Lee J, Lee C, Lee SY, Lee TS, Lee T, Lewis G, Lezcano S, Lin P, Luu T, Luu J, Marrs W, Marsh E, Marshall J, Min S, Minasian T, Minye H, Misra A, Morimoto M, Moshfegh Y, Murray J, Nguyen K, Nguyen C, Nodado E 2nd, ODonahue A, Onugha N, Orjiakor N, Padhiar B, Paul E, Pavel-Dinu M, Pavlenko A, Paz E, Phaklides S, Pham L, Poulose P, Powell R, Pusic A, Ramola D, Regalia K, Ribbens M, Rifai B, Saakyan M, Saarikoski P, Segura M, Shadpour F, Shemmassian A, Singh R, Singh V, Skinner E, Solomin D, Soneji K, Spivey K, Stageberg E, Stavchanskiy M, Tekchandani L, Thai L, Thiyanaratnam J, Tong M, Toor A, Tovar S, Trangsrud K, Tsang WY, Uemura M, Vollmer E, Weiss E, Wood D, Wu J, Wu S, Wu W, Xu Q, Yamauchi Y, Yarosh W, Yee L, Yen G, Banerjee U (2007). Genomewide clonal analysis of lethal mutations in the Drosophila melanogaster eye: comparison of the X chromosome and autosomes. Genetics, 177(2), 689-97. ()

    Commentary

    1. Schmidt B, Agarwal N (2021). Black Men Receiving Radiotherapy for Localized Prostate Cancer Have Improved Outcomes-Clinical Trial Access or Racial Advantage? JAMA Netw Open, 4(12), e2140692. ()

    Case Report

    1. Vilson FL, Lin SY, Schmidt B (2020). Resolution of bilateral testicular masses after viral infection. Urol Case Rep, 33, 101388. ()

    Editorial

    1. Bergman J, Schmidt B, Leppert JT (2020). Following Up on an Improperly Drawn Screening Test: The PSA Dilemma. Am J Med, 134(3), e145-e146. ()
  • News & Podcasts